Qualimedis est leader en France de la distribution des solutions de contrôle qualité en imagerie médicale, en radiothérapie, de logiciels et des accessoires de contention. Son récent développement s'est tourné vers la fourniture de solutions performantes, en accompagnant les centres de radiothérapie dans la prise en charge des patients dans les traitements complexes du cancer avec depuis 2019, l’accélérateur sans bunker ZAP X pour les traitements intracrâniens. En 2023, Qualimedis élargit ses activités en proposant les solutions innovantes de United Imaging Healthcare dans les domaines de l'imagerie, la médecine nucléaire et de la radiothérapie.
| Website | http://www.qualimedis.fr |
| Revenue | $4 million |
| Employees | 30 (17 on RocketReach) |
| Founded | 2008 |
| Phone | +33 1 43 53 68 20 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Health Care, Manufacturing |
| Web Rank | 8 Million |
| Keywords | Quality Control, Medical Imaging, Quality Assurance, Quality Control Solutions, Radiation Therapy, Medical Equipment, Medical Devices, Imaging Solutions, Healthcare Technology, Diagnostic Imaging, Medical Technology, Medical Software, Cancer Treatment, Healthcare Solutions, Treatment Planning, Medical Physics, Patient Care, Imrt |
| Competitors | Thermo Fisher Scientific, Cardinal Health, Medline Industries, LP, 3M, Henry Schein, Smith+Nephew, B. Braun Group, Getinge, Hollister Incorporated, Convatec Infusion Care +39 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Qualimedis employee's phone or email?
The Qualimedis annual revenue was $4 million in 2026.
Herve Servajean is the CEO and National Sales And Marketing Director of Qualimedis.
17 people are employed at Qualimedis.
Qualimedis is based in Joinville-le-Pont, Île-de-France.
The NAICS codes for Qualimedis are [334, 33].
The SIC codes for Qualimedis are [38, 384].